City

Chattanooga (1)

Fayetteville (1)

Hackensack (1)

Houston (1)

Nashville (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

TG Therapeutics, Inc. (1)

Collaborator

Intervention

tg-1801 (1)

ublituximab (1)

Study Documents

Intervention Type

biological (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

mcl

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting

CLL
+9 more

TG-1801
Ublituximab

Fayetteville, Arkansas
+4 more

Jan 20, 2023